Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response

被引:8
作者
Dittadi, Ruggero [1 ]
Afshar, Haleh [1 ]
Carraro, Paolo [1 ]
机构
[1] Osped Angelo, Lab Med Unit, Venice, Italy
关键词
Immune response; Time course; SARS-CoV-2; antibodies; Covid-19; management; Maglumi; Architect; Method comparison; ANTI-SARS-COV-2; ANTIBODIES;
D O I
10.1016/j.diagmicrobio.2020.115297
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The persistence of circulating antibodies to SARS-CoV-2 infection is not yet well known. We compare the results of 2 automated systems for the determination of IgG against SARS CoV-2 and assess the time-course of the IgG response. Methods: IgG were measured in 103 specimens of 55 patients with COVID-19 (time from the symptoms' onset: 3-187 days) using the automated tests "Abbott SARS-COV-2 IgG"and "MAGLUMI 2019-nCoV IgG". Results: The 2 methods had a concordance of 90.3%, but the quantitative correlation, although significant, showed dispersed results. All the specimens resulted positive after 17 days. However, the median concentrations of IgG rapidly increased up to 20 days and decreased for Maglumi IgG while Abbott IgG showed a constant trend up to 85 days, and then slowly declined. Conclusions: The titer of IgG against SARS-CoV-2 may significantly and rapidly decrease, but with a very different time course depending on the method used for the determination. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19
    Boelke, Edwin
    Matuschek, Christiane
    Fischer, Johannes C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) : 1694 - 1695
  • [2] Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
    Bryan, Andrew
    Pepper, Gregory
    Wener, Mark H.
    Fink, Susan L.
    Morishima, Chihiro
    Chaudhary, Anu
    Jerome, Keith R.
    Mathias, Patrick C.
    Greninger, Alexander L.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [3] Disappearance of antibodies to SARS-associated coronavirus after recovery
    Cao, Wu-Chun
    Liu, Wei
    Zhang, Pan-He
    Zhang, Fang
    Richardus, Jan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (11) : 1162 - 1163
  • [4] The early antibody response to SARS-Cov-2 infection
    Dittadi, Ruggero
    Afshar, Haleh
    Carraro, Paolo
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (10) : E201 - E203
  • [5] Humoral Immune Response to SARS-CoV-2 in Iceland
    Gudbjartsson, Daniel F.
    Norddahl, Gudmundur L.
    Melsted, Pall
    Gunnarsdottir, Kristbjorg
    Holm, Hilma
    Eythorsson, Elias
    Arnthorsson, Asgeir O.
    Helgason, Dadi
    Bjarnadottir, Kristbjorg
    Ingvarsson, Ragnar F.
    Thorsteinsdottir, Brynja
    Kristjansdottir, Steinunn
    Birgisdottir, Kolbrun
    Kristinsdottir, Anna M.
    Sigurdsson, Martin I.
    Arnadottir, Gudny A.
    Ivarsdottir, Erna V.
    Andresdottir, Margret
    Jonsson, Frosti
    Agustsdottir, Arna B.
    Berglund, Jonas
    Eiriksdottir, Berglind
    Fridriksdottir, Run
    Gardarsdottir, Elisabet E.
    Gottfredsson, Magnus
    Gretarsdottir, Olafia S.
    Gudmundsdottir, Steinunn
    Gudmundsson, Kjartan R.
    Gunnarsdottir, Thora R.
    Gylfason, Arnaldur
    Helgason, Agnar
    Jensson, Brynjar O.
    Jonasdottir, Aslaug
    Jonsson, Hakon
    Kristjansson, Thordur
    Kristinsson, Karl G.
    Magnusdottir, Droplaug N.
    Magnusson, Olafur T.
    Olafsdottir, Lovisa B.
    Rognvaldsson, Solvi
    le Roux, Louise
    Sigmundsdottir, Gudrun
    Sigurdsson, Asgeir
    Sveinbjornsson, Gardar
    Sveinsdottir, Kristin E.
    Sveinsdottir, Maney
    Thorarensen, Emil A.
    Thorbjornsson, Bjarni
    Thordardottir, Marianna
    Saemundsdottir, Jona
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) : 1724 - 1734
  • [6] Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
    Ibarrondo, F. Javier
    Fulcher, Jennifer A.
    Yang, Otto O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11) : 1085 - 1087
  • [7] Jaaskelainen AJ, 2020, J CLIN VIROL, V129, DOI DOI 10.1016/j.jcv.2020.104512
  • [8] COVID-19 and Postinfection Immunity Limited Evidence, Many Remaining Questions
    Kirkcaldy, Robert D.
    King, Brian A.
    Brooks, John T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (22): : 2245 - 2246
  • [9] Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
    Kohmer, Niko
    Westhaus, Sandra
    Ruehl, Cornelia
    Ciesek, Sandra
    Rabenau, Holger F.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [10] Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
    Kontou, Panagiota, I
    Braliou, Georgia G.
    Dimou, Niki L.
    Nikolopoulos, Georgios
    Bagos, Pantelis G.
    [J]. DIAGNOSTICS, 2020, 10 (05)